StemGenex Comments on FDA Docket to Support Stem Cell Therapy – PR Newswire (press release)
PR Newswire (press release) |
StemGenex Comments on FDA Docket to Support Stem Cell Therapy
PR Newswire (press release) LA JOLLA, Calif., Nov. 29, 2016 /PRNewswire/ — StemGenex recently submitted comments to the Food and Drug Administration (FDA) docket on the future regulation of adult adipose-derived stem cell treatments, "Draft Guidances Relating to the Regulation … |
